Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib

BACKGROUND: Tofacitinib is an oral, small molecule Janus kinase inhibitor that is being investigated for ulcerative colitis (UC). Tofacitinib is approved for rheumatoid arthritis and psoriatic arthritis, where it has been shown to increase herpes zoster (HZ) risk. We evaluated HZ risk among UC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Winthrop, Kevin L, Melmed, Gil Y, Vermeire, Séverine, Long, Millie D, Chan, Gary, Pedersen, Ronald D, Lawendy, Nervin, Thorpe, Andrew J, Nduaka, Chudy I, Su, Chinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140434/
https://www.ncbi.nlm.nih.gov/pubmed/29850873
http://dx.doi.org/10.1093/ibd/izy131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140434/
https://www.ncbi.nlm.nih.gov/pubmed/29850873
http://dx.doi.org/10.1093/ibd/izy131

Ejemplares similares